Product correctly added to cart.

discount label
3-Methyl-1,5-naphthyridine
View 3D

Biosynth logo

3-Methyl-1,5-naphthyridine

CAS: 18937-71-8

Ref. 3D-TAA93771

50mg
245.00 €
500mg
974.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025

Product Information

Name:
3-Methyl-1,5-naphthyridine
Description:

3-Methyl-1,5-naphthyridine is a 5-hydroxytryptamine (5HT) receptor antagonist that was synthesized and tested for the first time in humans. The pharmacokinetic properties of 3-methyl-1,5-naphthyridine were studied in humans and it was shown that the drug has a short half life of about 1.8 hours after oral administration. It also showed antibacterial efficacy against Escherichia coli and Enterococcus faecalis when tested in vitro. In addition, 3-methyl-1,5-naphthyridine has been shown to inhibit the activity of 5HT2A receptors by binding to them competitively. The molecular modeling studies suggest that 3-methyl-1,5-naphthyridine binds to the microsomal proteins on the surface of bacteria cells with its furyl group. This binding inhibits enzymes such as cholinesterase inhibitors and thus prevents

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
144.17 g/mol
Formula:
C9H8N2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-TAA93771 3-Methyl-1,5-naphthyridine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".